Proteomics and autoantibody;Protéomique et auto-anticorps

Medecine/Sciences

Volumn 21, Issue 8-9, 2005, Pages 759-764

  Machour, Nadine ^a   Gilbert, Danìle ^a   Vittecoq, Olivier ^a   Costa, Odile ^a   Tron, François ^a   Charlionet, Roland ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; BIOLOGICAL MARKER; CROSS REACTING ANTIBODY; RECOMBINANT PROTEIN;

AFFINITY CHROMATOGRAPHY; ANTIGEN ANTIBODY COMPLEX; ANTIGEN ANTIBODY REACTION; ANTIGEN PURIFICATION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CROSS REACTION; DIAGNOSTIC VALUE; HUMAN; INFLAMMATION; MEMBRANE FILTER; PATHOPHYSIOLOGY; PROTEOMICS; REVIEW; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; TARGET ORIENTED PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

EID: 30344462723     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2005218-9759     Document Type: Review

References (27)

1. Schwartz RS. Autoimmunity and autoimmune diseases. In: Paul WE, ed. Fundamental immunology. New York: Raven Press, 1993: 1033-97.
2. Oppezzo P, Dighiero G. Autoantibodies, tolerance and autoimmunity. Pathol Biol 2003; 51: 297-304.
3. Holman HR, Kunkel HG. Affinity between the lupus erythematosus serum factor and cell nuclei and nucleoprotein. Science 1957; 126: 162-3.
4. Ulvestad E, Kanestrom A, Madland TM, et al. Evaluation of diagnostic tests for antinuclear antibodies in rheumatological practice. Scand J Immunol 2000; 52: 309-15.
5. Sahin U, Tureci O, Pfreundschuh M. Serological identification of human tumor antigens. Curr Opin Immunol 1997; 9: 709-16.
6. Robinson WH, Steinman L, Utz PJ. Protein arrays for autoantibody profiling and fine-specifcity mapping. Proteomics 2003; 3: 2077-84.
7. MacBeath G, Schreiber SL. Printing proteins as microarrays for high-throughput function determination. Science 2000; 289: 1760-3.
8. Lueking A, Horn M, Eickhoff H, et al. Protein microarrays for gene expression and antibody screening. Anal Biochem 1999; 270: 103-11.
9. Angenendt P, Glökler J, Sobek J, et al. Next generation of protein microarray support materials: evaluation for protein and antibody microarray applications. J Chromatogr A 2003; 1009: 97-104.
10. Lueking A, Possling A, Huber O, et al. A non-redundant human protein chip for antibody screening and serum profiling. Mol Cell Proteomics 2003; 12: 1342-9.
11. Schmitt J, Papisch W. Recombinant autoantigens. Autoimmun Rev 2002; 1: 79-88.
12. Makrides SC. Strategies for achieving high-level expression of genes in E. coli. Microbiol Rev 1996; 60: 512-38.
13. Grus FH, Joachim SC, Pfeiffer N. Analysis of complex autoantibody repertoires by surface-enhanced desorption/ionisation-time of flight mass spectrometry. Proteomics 2003; 3: 957-61.
14. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionisation-time of flight-mass spectrometry. Electrophoresis 2000; 21: 1164-77.
15. Gravett MG, Novy MJ, Rosenfeld RG, et al. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA 2004; 292: 462-9.
16. Caputo E, Moharram R, Martin BM. Methods for on-chip protein analysis. Anal Biochem 2003; 321: 116-24.
17. Zhang X, Leung S-M, Morris CR, Shigenaga MK. Evaluation of a novel, integrated approach using functionnalized magnetic beads, bench-top Maldi-Tof MS with prestructured sample supports, and pattern recognition software for profiling potential biomarkers in human plasma. J Biomol Techn 2004; 15: 167-75.
18. Rabilloud T. Two-dimensional gel electrophoresis in proteomics: old, old fashioned but it still climbs up the mountains. Proteomics 2002; 2: 3-10.
19. Thebault S, Gilbert D, Machour N, et al. Two-dimensional electrophoresis and mass spectrometry identification of proteins bound by a murine monoclonal antti-cardiolipin antibody: a powerful technique to characterize the cross-reactivity of a single autoantibody. Electrophoresis 2000; 21: 2531-9.
20. LeNaour F, Brichory F, Misek DE, et al. A distinct repertoire of autoantibodies hepatocellular carcinoma identified by proteomic analysis. Mol Cell Proteomics 2002; 1: 197-203.
21. Thebault S, Gilbert D, Hubert M, et al. Orderly pattern of development of the autoantibody response in (NZWxBXSB)F1 lupus mice: characterization of target antigens and antigen spreading by two-dimensional gel electrophoresis and mass spectrometry. J Immunol 2002; 169: 4046-53.
22. Saulot V, Vittecoq O, Charlionet R, et al. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early RA. Arthr. Rheum. 2002; 46: 1196-1201.
23. Unwin RD, Harnden P, Pappin D, et al. Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma. Proteomics 2003; 3: 45-55.
24. Latif N, Baker CS, Dunn MJ, et al. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and western blotting. J Am Coll Cardiol 1993; 22: 1378-84.
25. Pohlner K, Portig I, Pankuweit S, et al. Identification of mitochondrial antigens recognized by antibodies in sera of patients with idiopathic dilated cardiomyopathy by two-dimensional gel electrophoresis and protein sequencing. Am J Cardiol 1997; 80: 1040-5.
26. Almeras L, Lefranc D, Drobecq H, et al. New antigenic candidates in multiple sclerosis: a serological proteomic analysis. Proteomics 2004; 7: 2184-94.
27. Lefranc D, Almeras L, Dubucquoi S, et al. Distortion of the self-reactive IgG antibody repertoire in multiple sclerosis as a new diagnostic tool. J Immunol 2004; 172: 669-78.